Amit Kakar will supervise a Singapore office that will spearhead the pharmaceutical company's corporate venturing investments across Asia.

Denmark-based pharmaceutical firm Novo plans to open an office in Singapore in August this year in order to oversee investments in Asia, it announced yesterday. Although Novo Holdings, the holding company for the Novo Group, is an active investor in Europe and the United States, it has yet to participate in Asian deals, and the…

The rest of this content is only accessible to Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.